HSCS
HeartSciences (HSCS)
NASDAQ
$1.97-$0.10 (-4.83%)
Price as of Jun 03, 2026 6:34 PM EDT
  • $5.3M
    Market Cap
  • -47.46%
    1-Year Change
  • Medical Devices
    Industry
Annual
Quarterly
04/30/2025
04/30/2024
04/30/2023
Income Statement
Total Operating Revenue
4,350
-76.61%
18,600
+261.17%
5,150
N/A
Cost of Revenue
1,880
-69.08%
6,081
+117.49%
2,796
N/A
Gross Profit
2,470
-80.27%
12,519
+431.82%
2,354
N/A
Sales and Marketing Expense
4.0M
+15.38%
3.4M
-5.88%
3.7M
N/A
Research and Development Expense
-4.4M
+52.37%
-2.9M
+16.97%
-2.5M
N/A
Depreciation and Amortization Expense
37,599
+34.80%
27,892
+3.63%
26,915
N/A
Total Operating Expenses
8.4M
+32.24%
6.3M
+3.32%
6.1M
N/A
Operating Profit
-8.4M
+32.46%
-6.3M
+3.15%
-6.1M
N/A
Interest Income
87,795
+60.67%
54,642
+2,856.82%
1,848
N/A
Interest Expense
N/A
N/A
-354,080
+45.61%
-243,174
N/A
Interest Income and Expense and Net
87,795
+129.32%
-299,438
+24.08%
-241,326
N/A
Total Nonoperating Income and Expense
-412,658
+37.81%
-299,438
+24.08%
-241,326
N/A
Income before Taxes
-8.4M
+32.46%
-6.3M
+3.15%
-6.1M
N/A
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-8.8M
+32.70%
-6.6M
+3.95%
-6.4M
N/A
Net Income from Continuing Operations Applicable to Common
-8.8M
+32.70%
-6.6M
+3.95%
-6.4M
N/A
Basic EPS and Net Income
-9.34
-50.84%
-19.00
+2,275.00%
-0.80
N/A
Diluted EPS and Net Income
-9.34
-50.84%
-19.00
+2,275.00%
-0.80
N/A
Basic Weighted Average Shares
938,257
+166.16%
352,520
-95.57%
8.0M
N/A
Diluted Weighted Average Shares
938,257
+166.16%
352,520
-95.57%
8.0M
N/A
Balance Sheet
Cash and Cash Equivalents
1.1M
-81.09%
5.8M
+249.76%
1.7M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
1.1M
-81.09%
5.8M
+249.76%
1.7M
N/A
Total Current Assets
2.2M
-70.47%
7.4M
+172.71%
2.7M
N/A
Accumulated Depreciation
537,358
+7.52%
499,759
+5.91%
471,867
N/A
Property and Plant and Equipment and Net
63,549
-35.15%
97,991
+59.52%
61,428
N/A
Total Long-Term Assets
354,474
-55.19%
790,979
+233.26%
237,349
N/A
Total Assets
4.2M
-55.56%
9.5M
+189.09%
3.3M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
2.6M
+410.23%
500,000
0.00%
500,000
N/A
Total Current Liabilities
3.7M
+111.40%
1.8M
-4.43%
1.8M
N/A
Total Long-Term Debt
500,000
N/A
0
-100.00%
500,000
N/A
Total Long-Term Liabilities
314,527
-27.54%
434,045
-64.53%
1.2M
N/A
Total Liabilities
4.0M
+83.81%
2.2M
-28.49%
3.1M
N/A
Retained Earnings
-76.1M
+13.01%
-67.4M
+10.87%
-60.8M
N/A
Total Stockholders Equity
205,171
-97.20%
7.3M
+3,073.75%
230,557
N/A
Total Shares Outstanding
1.1M
+65.40%
676,598
-93.31%
10.1M
N/A
Cash Flow
Cash from Operating Activities
-7.4M
+22.12%
-6.1M
+5.14%
-5.8M
N/A
Capital Expenditures
3,157
-95.10%
64,455
+252.06%
18,308
N/A
Cash from Investing Activities
-30,188
-75.90%
-125,271
+584.24%
-18,308
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
2.7M
-73.57%
10.3M
+58.29%
6.5M
N/A
Financials Ratio
Gross Margin
56.78%
-15.64%
67.31%
N/A
N/A
N/A
Operating Margin
-192,013.13%
+466.38%
-33,901.99%
N/A
N/A
N/A
Return on Assets
-127.72%
+23.66%
-103.28%
N/A
N/A
N/A
Return on Equity
-233.04%
+33.15%
-175.02%
N/A
N/A
N/A
Revenue Growth
-76.61%
-129.34%
261.17%
N/A
N/A
N/A
Current Ratio
0.59
-86.03%
4.20
N/A
N/A
N/A
Cash Ratio
0.30
-91.06%
3.32
N/A
N/A
N/A
Debt-to-Equity Ratio
14.87
+21,673.65%
0.07
N/A
N/A
N/A
Debt-to-Assets Ratio
0.72
+1,273.57%
0.05
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow